Top Quality Pharmaceutical Powder Raloxifene Hydrochloride CAS: 82640-04-8
- Κατασκευαστής: Dewael
- Δοκιμασία προϊόν: 99%+
- Εμφάνιση:light yellow powder
- Τόπο καταγωγής: Κίνα
- Πιστοποίηση: SGS,ISO9001, GMP
- Ελάχιστη ποσότητα παραγγελίας: 10σολ
- λεπτομέρειες συσκευασίας: 1 κιλό/τσάντα αλουμινίου,25kg/drum ή ως απαιτήσεις σας
- Ωρα παράδοσης: Στα πλαίσια 12 ώρες μετά τη λήψη της πληρωμής σας
- Οροι πληρωμής: Δυτική Ένωση, MoneyGram,Bitcoin,Τραπεζική μεταφορά
- Αποστολή: EMS,DHL,Fedex,UPS,TNT και ούτω καθεξής.
- Πολιτική: Re-Shipping Πολιτική
- δυνατότητα εφοδιασμού: 500-600kg/μήνα
Top Quality Pharmaceutical Powder Raloxifene Hydrochloride CAS: 82640-04-8
Καθέκαστα:
Ονομα:raloxifene hcl, Υδροχλωρική ραλοξιφαίνη
CAS Αρ.:82640-04-8
MF:C28H28ClNO4S
Use:antineoplastic
Εμφάνιση:light yellow powder
Προσδιορισμός:
| όνομα προϊόντος: | Υδροχλωρική ραλοξιφαίνη |
| CAS: | 82640-04-8 |
| MF: | C28H28ClNO4S |
| MW: | 510.04 |
| Κατηγορίες προϊόντων: | Active Pharmaceutical Ingredients;Raloxifene;Intracellular receptor;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;Pharmaceutical intermediate |
| Mol File: | 82640-04-8.mol |
| mp | 250-253ΝΤΟ |
| storage temp. | -20°C Freezer |
| solubility | DMSO: 28 mg/mL, soluble |
| form | solid |
| color | light yellow |
| CAS DataBase Reference | 82640-04-8(CAS DataBase Reference) |
| Χημικές ιδιότητες | Light-Yellow Solid |
| Χρήση | A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic. |
Raloxifene Hydrochloride Description:
Raloxifene (marketed as Evista) is an oral selective estrogen receptor modulator (SERM) that has estrogenic actions on bone and anti-estrogenic actions on the uterus and breast. It is used in the prevention of osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.
Raloxifene Hydrochloride Application:
Because of Raloxifene’s greater differences in its selectivity of Estrogen agonism and antagonism in different tissues in the body, there is ongoing investigation of its application in other diseases, including prostate cancer, acromegaly, uterine cancer, cardiovascular disease, and breast cancer.
Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women. It is also used for reduction of risk and treatment of invasive breast cancer, and it also reduces breast density.For either osteoporosis treatment or prevention, supplemental calcium and/or vitamin D should be added to the diet if daily intake is inadequate.
Raloxifene is used to prevent and treat bone loss (οστεοπόρωση) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.
Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.
———————————————————————————————————————————————————————————————————————————————————————-
Επικοινώνησε τώρα
Κριτικές
Δεν υπάρχουν σχόλια ακόμη.